MM
MetroWest Medical Center at IDWeek 2026
Oct 21–24, 2026 Washington, DC ~12k attendees Website
MetroWest Medical Center brings 5 presentations to IDWeek 2026 in Washington. Its program centres on HIV drug resistance in children and on treating resistant bacterial and fungal infections. It reviews how resistance has shifted among young people with HIV in the dolutegravir era, and how ESBL-active first therapy affects in-hospital deaths from ESBL bloodstream infections.
| Organization | IDWeek 2026 Attendance |
|---|---|
MM MetroWest Medical Center Framingham, MA | |
Poster Thu Oct 22 12:15pm–1:30pm Declining HIV-1 Drug Resistance in the Dolutegravir Era Among Children and Adolescents: A Systematic Review and Meta-Analysis of Global Temporal Trends Poster Thu Oct 22 12:15pm–1:30pm Effect of Empiric ESBL-Active Versus Nonactive Therapy on In-Hospital Mortality in Extended-Spectrum β-Lactamase–Producing Bloodstream Infection: A Pooled Analysis Poster Thu Oct 22 12:15pm–1:30pm Emerging INSTI Resistance in Children and Adolescents Living with HIV: A Systematic Review and Meta-Analysis in the Dolutegravir Era Poster Fri Oct 23 12:15pm–1:30pm Antifungal Prophylaxis in Acute Myeloid Leukemia Treated with Venetoclax and Hypomethylating Agents: A Systematic Review and Meta-Analysis Poster Sat Oct 24 12:15pm–1:30pm HIV Status, Stigma, and Financial Stress as Predictors of Loneliness and Depression in a Community Hospital HIV Clinic Population |
Instantly find 20 buyers from MetroWest Medical Center
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction